Global Tumor Genomics Market Research Report 2025(Status and Outlook)
Report Overview
The tumor genomics market encompasses the study and application of genomic technologies to analyze tumor DNA, RNA, and other molecular markers to understand cancer biology, improve diagnostics, and guide personalized treatment strategies. This field leverages next-generation sequencing (NGS), bioinformatics, and other advanced techniques to identify genetic mutations, gene expression patterns, and biomarkers that drive tumor growth, progression, and drug resistance. Tumor genomics plays a critical role in precision oncology, enabling targeted therapies, immunotherapy selection, and minimal residual disease monitoring. The market includes diagnostic tools, clinical testing services, and research applications, with growing demand driven by the increasing incidence of cancer, advancements in genomic technologies, and the shift toward personalized medicine. Key players include diagnostic companies, biotech firms, and academic institutions, while regulatory frameworks and reimbursement policies significantly influence market dynamics.
The global Tumor Genomics market size was estimated at USD 4154.57 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 12.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Tumor Genomics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Tumor Genomics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Tumor Genomics market.
Global Tumor Genomics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott Laboratories
Agilent TechnologiesInc
Bio-Rad LaboratoriesInc.
Danaher Corporation
F. Hoffmann-La Roche Ltd
Fluidigm Corporation
General Electric Company
IlluminaInc.
Merck KGaA
Myriad GeneticsInc.
Pacific Biosciences of CaliforniaInc.
PerkinElmer
QIAGEN
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Market Segmentation (by Type)
Assays and Kits
Instrument
Market Segmentation (by Application)
Diagnostics and Monitoring
Drug Discovery and Development
Biomarker Discovery
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Tumor Genomics Market
Overview of the regional outlook of the Tumor Genomics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tumor Genomics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Tumor Genomics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The tumor genomics market encompasses the study and application of genomic technologies to analyze tumor DNA, RNA, and other molecular markers to understand cancer biology, improve diagnostics, and guide personalized treatment strategies. This field leverages next-generation sequencing (NGS), bioinformatics, and other advanced techniques to identify genetic mutations, gene expression patterns, and biomarkers that drive tumor growth, progression, and drug resistance. Tumor genomics plays a critical role in precision oncology, enabling targeted therapies, immunotherapy selection, and minimal residual disease monitoring. The market includes diagnostic tools, clinical testing services, and research applications, with growing demand driven by the increasing incidence of cancer, advancements in genomic technologies, and the shift toward personalized medicine. Key players include diagnostic companies, biotech firms, and academic institutions, while regulatory frameworks and reimbursement policies significantly influence market dynamics.
The global Tumor Genomics market size was estimated at USD 4154.57 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 12.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Tumor Genomics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Tumor Genomics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Tumor Genomics market.
Global Tumor Genomics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott Laboratories
Agilent TechnologiesInc
Bio-Rad LaboratoriesInc.
Danaher Corporation
F. Hoffmann-La Roche Ltd
Fluidigm Corporation
General Electric Company
IlluminaInc.
Merck KGaA
Myriad GeneticsInc.
Pacific Biosciences of CaliforniaInc.
PerkinElmer
QIAGEN
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Market Segmentation (by Type)
Assays and Kits
Instrument
Market Segmentation (by Application)
Diagnostics and Monitoring
Drug Discovery and Development
Biomarker Discovery
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Tumor Genomics Market
Overview of the regional outlook of the Tumor Genomics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tumor Genomics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Tumor Genomics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Tumor Genomics
1.2 Key Market Segments
1.2.1 Tumor Genomics Segment by Type
1.2.2 Tumor Genomics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TUMOR GENOMICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tumor Genomics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Tumor Genomics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TUMOR GENOMICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Tumor Genomics Product Life Cycle
3.3 Global Tumor Genomics Sales by Manufacturers (2020-2025)
3.4 Global Tumor Genomics Revenue Market Share by Manufacturers (2020-2025)
3.5 Tumor Genomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Tumor Genomics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Tumor Genomics Market Competitive Situation and Trends
3.8.1 Tumor Genomics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Tumor Genomics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 TUMOR GENOMICS INDUSTRY CHAIN ANALYSIS
4.1 Tumor Genomics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TUMOR GENOMICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Tumor Genomics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Tumor Genomics Market
5.7 ESG Ratings of Leading Companies
6 TUMOR GENOMICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tumor Genomics Sales Market Share by Type (2020-2025)
6.3 Global Tumor Genomics Market Size Market Share by Type (2020-2025)
6.4 Global Tumor Genomics Price by Type (2020-2025)
7 TUMOR GENOMICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tumor Genomics Market Sales by Application (2020-2025)
7.3 Global Tumor Genomics Market Size (M USD) by Application (2020-2025)
7.4 Global Tumor Genomics Sales Growth Rate by Application (2020-2025)
8 TUMOR GENOMICS MARKET SALES BY REGION
8.1 Global Tumor Genomics Sales by Region
8.1.1 Global Tumor Genomics Sales by Region
8.1.2 Global Tumor Genomics Sales Market Share by Region
8.2 Global Tumor Genomics Market Size by Region
8.2.1 Global Tumor Genomics Market Size by Region
8.2.2 Global Tumor Genomics Market Size Market Share by Region
8.3 North America
8.3.1 North America Tumor Genomics Sales by Country
8.3.2 North America Tumor Genomics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Tumor Genomics Sales by Country
8.4.2 Europe Tumor Genomics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Tumor Genomics Sales by Region
8.5.2 Asia Pacific Tumor Genomics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Tumor Genomics Sales by Country
8.6.2 South America Tumor Genomics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Tumor Genomics Sales by Region
8.7.2 Middle East and Africa Tumor Genomics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 TUMOR GENOMICS MARKET PRODUCTION BY REGION
9.1 Global Production of Tumor Genomics by Region(2020-2025)
9.2 Global Tumor Genomics Revenue Market Share by Region (2020-2025)
9.3 Global Tumor Genomics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Tumor Genomics Production
9.4.1 North America Tumor Genomics Production Growth Rate (2020-2025)
9.4.2 North America Tumor Genomics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Tumor Genomics Production
9.5.1 Europe Tumor Genomics Production Growth Rate (2020-2025)
9.5.2 Europe Tumor Genomics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Tumor Genomics Production (2020-2025)
9.6.1 Japan Tumor Genomics Production Growth Rate (2020-2025)
9.6.2 Japan Tumor Genomics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Tumor Genomics Production (2020-2025)
9.7.1 China Tumor Genomics Production Growth Rate (2020-2025)
9.7.2 China Tumor Genomics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Basic Information
10.1.2 Abbott Laboratories Tumor Genomics Product Overview
10.1.3 Abbott Laboratories Tumor Genomics Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 Agilent TechnologiesInc
10.2.1 Agilent TechnologiesInc Basic Information
10.2.2 Agilent TechnologiesInc Tumor Genomics Product Overview
10.2.3 Agilent TechnologiesInc Tumor Genomics Product Market Performance
10.2.4 Agilent TechnologiesInc Business Overview
10.2.5 Agilent TechnologiesInc SWOT Analysis
10.2.6 Agilent TechnologiesInc Recent Developments
10.3 Bio-Rad LaboratoriesInc.
10.3.1 Bio-Rad LaboratoriesInc. Basic Information
10.3.2 Bio-Rad LaboratoriesInc. Tumor Genomics Product Overview
10.3.3 Bio-Rad LaboratoriesInc. Tumor Genomics Product Market Performance
10.3.4 Bio-Rad LaboratoriesInc. Business Overview
10.3.5 Bio-Rad LaboratoriesInc. SWOT Analysis
10.3.6 Bio-Rad LaboratoriesInc. Recent Developments
10.4 Danaher Corporation
10.4.1 Danaher Corporation Basic Information
10.4.2 Danaher Corporation Tumor Genomics Product Overview
10.4.3 Danaher Corporation Tumor Genomics Product Market Performance
10.4.4 Danaher Corporation Business Overview
10.4.5 Danaher Corporation Recent Developments
10.5 F. Hoffmann-La Roche Ltd
10.5.1 F. Hoffmann-La Roche Ltd Basic Information
10.5.2 F. Hoffmann-La Roche Ltd Tumor Genomics Product Overview
10.5.3 F. Hoffmann-La Roche Ltd Tumor Genomics Product Market Performance
10.5.4 F. Hoffmann-La Roche Ltd Business Overview
10.5.5 F. Hoffmann-La Roche Ltd Recent Developments
10.6 Fluidigm Corporation
10.6.1 Fluidigm Corporation Basic Information
10.6.2 Fluidigm Corporation Tumor Genomics Product Overview
10.6.3 Fluidigm Corporation Tumor Genomics Product Market Performance
10.6.4 Fluidigm Corporation Business Overview
10.6.5 Fluidigm Corporation Recent Developments
10.7 General Electric Company
10.7.1 General Electric Company Basic Information
10.7.2 General Electric Company Tumor Genomics Product Overview
10.7.3 General Electric Company Tumor Genomics Product Market Performance
10.7.4 General Electric Company Business Overview
10.7.5 General Electric Company Recent Developments
10.8 IlluminaInc.
10.8.1 IlluminaInc. Basic Information
10.8.2 IlluminaInc. Tumor Genomics Product Overview
10.8.3 IlluminaInc. Tumor Genomics Product Market Performance
10.8.4 IlluminaInc. Business Overview
10.8.5 IlluminaInc. Recent Developments
10.9 Merck KGaA
10.9.1 Merck KGaA Basic Information
10.9.2 Merck KGaA Tumor Genomics Product Overview
10.9.3 Merck KGaA Tumor Genomics Product Market Performance
10.9.4 Merck KGaA Business Overview
10.9.5 Merck KGaA Recent Developments
10.10 Myriad GeneticsInc.
10.10.1 Myriad GeneticsInc. Basic Information
10.10.2 Myriad GeneticsInc. Tumor Genomics Product Overview
10.10.3 Myriad GeneticsInc. Tumor Genomics Product Market Performance
10.10.4 Myriad GeneticsInc. Business Overview
10.10.5 Myriad GeneticsInc. Recent Developments
10.11 Pacific Biosciences of CaliforniaInc.
10.11.1 Pacific Biosciences of CaliforniaInc. Basic Information
10.11.2 Pacific Biosciences of CaliforniaInc. Tumor Genomics Product Overview
10.11.3 Pacific Biosciences of CaliforniaInc. Tumor Genomics Product Market Performance
10.11.4 Pacific Biosciences of CaliforniaInc. Business Overview
10.11.5 Pacific Biosciences of CaliforniaInc. Recent Developments
10.12 PerkinElmer
10.12.1 PerkinElmer Basic Information
10.12.2 PerkinElmer Tumor Genomics Product Overview
10.12.3 PerkinElmer Tumor Genomics Product Market Performance
10.12.4 PerkinElmer Business Overview
10.12.5 PerkinElmer Recent Developments
10.13 QIAGEN
10.13.1 QIAGEN Basic Information
10.13.2 QIAGEN Tumor Genomics Product Overview
10.13.3 QIAGEN Tumor Genomics Product Market Performance
10.13.4 QIAGEN Business Overview
10.13.5 QIAGEN Recent Developments
10.14 Siemens Healthineers AG
10.14.1 Siemens Healthineers AG Basic Information
10.14.2 Siemens Healthineers AG Tumor Genomics Product Overview
10.14.3 Siemens Healthineers AG Tumor Genomics Product Market Performance
10.14.4 Siemens Healthineers AG Business Overview
10.14.5 Siemens Healthineers AG Recent Developments
10.15 Thermo Fisher Scientific Inc.
10.15.1 Thermo Fisher Scientific Inc. Basic Information
10.15.2 Thermo Fisher Scientific Inc. Tumor Genomics Product Overview
10.15.3 Thermo Fisher Scientific Inc. Tumor Genomics Product Market Performance
10.15.4 Thermo Fisher Scientific Inc. Business Overview
10.15.5 Thermo Fisher Scientific Inc. Recent Developments
11 TUMOR GENOMICS MARKET FORECAST BY REGION
11.1 Global Tumor Genomics Market Size Forecast
11.2 Global Tumor Genomics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Tumor Genomics Market Size Forecast by Country
11.2.3 Asia Pacific Tumor Genomics Market Size Forecast by Region
11.2.4 South America Tumor Genomics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Tumor Genomics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Tumor Genomics Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Tumor Genomics by Type (2026-2033)
12.1.2 Global Tumor Genomics Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Tumor Genomics by Type (2026-2033)
12.2 Global Tumor Genomics Market Forecast by Application (2026-2033)
12.2.1 Global Tumor Genomics Sales (K Units) Forecast by Application
12.2.2 Global Tumor Genomics Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Tumor Genomics
1.2 Key Market Segments
1.2.1 Tumor Genomics Segment by Type
1.2.2 Tumor Genomics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TUMOR GENOMICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tumor Genomics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Tumor Genomics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TUMOR GENOMICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Tumor Genomics Product Life Cycle
3.3 Global Tumor Genomics Sales by Manufacturers (2020-2025)
3.4 Global Tumor Genomics Revenue Market Share by Manufacturers (2020-2025)
3.5 Tumor Genomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Tumor Genomics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Tumor Genomics Market Competitive Situation and Trends
3.8.1 Tumor Genomics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Tumor Genomics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 TUMOR GENOMICS INDUSTRY CHAIN ANALYSIS
4.1 Tumor Genomics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TUMOR GENOMICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Tumor Genomics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Tumor Genomics Market
5.7 ESG Ratings of Leading Companies
6 TUMOR GENOMICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tumor Genomics Sales Market Share by Type (2020-2025)
6.3 Global Tumor Genomics Market Size Market Share by Type (2020-2025)
6.4 Global Tumor Genomics Price by Type (2020-2025)
7 TUMOR GENOMICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tumor Genomics Market Sales by Application (2020-2025)
7.3 Global Tumor Genomics Market Size (M USD) by Application (2020-2025)
7.4 Global Tumor Genomics Sales Growth Rate by Application (2020-2025)
8 TUMOR GENOMICS MARKET SALES BY REGION
8.1 Global Tumor Genomics Sales by Region
8.1.1 Global Tumor Genomics Sales by Region
8.1.2 Global Tumor Genomics Sales Market Share by Region
8.2 Global Tumor Genomics Market Size by Region
8.2.1 Global Tumor Genomics Market Size by Region
8.2.2 Global Tumor Genomics Market Size Market Share by Region
8.3 North America
8.3.1 North America Tumor Genomics Sales by Country
8.3.2 North America Tumor Genomics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Tumor Genomics Sales by Country
8.4.2 Europe Tumor Genomics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Tumor Genomics Sales by Region
8.5.2 Asia Pacific Tumor Genomics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Tumor Genomics Sales by Country
8.6.2 South America Tumor Genomics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Tumor Genomics Sales by Region
8.7.2 Middle East and Africa Tumor Genomics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 TUMOR GENOMICS MARKET PRODUCTION BY REGION
9.1 Global Production of Tumor Genomics by Region(2020-2025)
9.2 Global Tumor Genomics Revenue Market Share by Region (2020-2025)
9.3 Global Tumor Genomics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Tumor Genomics Production
9.4.1 North America Tumor Genomics Production Growth Rate (2020-2025)
9.4.2 North America Tumor Genomics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Tumor Genomics Production
9.5.1 Europe Tumor Genomics Production Growth Rate (2020-2025)
9.5.2 Europe Tumor Genomics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Tumor Genomics Production (2020-2025)
9.6.1 Japan Tumor Genomics Production Growth Rate (2020-2025)
9.6.2 Japan Tumor Genomics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Tumor Genomics Production (2020-2025)
9.7.1 China Tumor Genomics Production Growth Rate (2020-2025)
9.7.2 China Tumor Genomics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Basic Information
10.1.2 Abbott Laboratories Tumor Genomics Product Overview
10.1.3 Abbott Laboratories Tumor Genomics Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 Agilent TechnologiesInc
10.2.1 Agilent TechnologiesInc Basic Information
10.2.2 Agilent TechnologiesInc Tumor Genomics Product Overview
10.2.3 Agilent TechnologiesInc Tumor Genomics Product Market Performance
10.2.4 Agilent TechnologiesInc Business Overview
10.2.5 Agilent TechnologiesInc SWOT Analysis
10.2.6 Agilent TechnologiesInc Recent Developments
10.3 Bio-Rad LaboratoriesInc.
10.3.1 Bio-Rad LaboratoriesInc. Basic Information
10.3.2 Bio-Rad LaboratoriesInc. Tumor Genomics Product Overview
10.3.3 Bio-Rad LaboratoriesInc. Tumor Genomics Product Market Performance
10.3.4 Bio-Rad LaboratoriesInc. Business Overview
10.3.5 Bio-Rad LaboratoriesInc. SWOT Analysis
10.3.6 Bio-Rad LaboratoriesInc. Recent Developments
10.4 Danaher Corporation
10.4.1 Danaher Corporation Basic Information
10.4.2 Danaher Corporation Tumor Genomics Product Overview
10.4.3 Danaher Corporation Tumor Genomics Product Market Performance
10.4.4 Danaher Corporation Business Overview
10.4.5 Danaher Corporation Recent Developments
10.5 F. Hoffmann-La Roche Ltd
10.5.1 F. Hoffmann-La Roche Ltd Basic Information
10.5.2 F. Hoffmann-La Roche Ltd Tumor Genomics Product Overview
10.5.3 F. Hoffmann-La Roche Ltd Tumor Genomics Product Market Performance
10.5.4 F. Hoffmann-La Roche Ltd Business Overview
10.5.5 F. Hoffmann-La Roche Ltd Recent Developments
10.6 Fluidigm Corporation
10.6.1 Fluidigm Corporation Basic Information
10.6.2 Fluidigm Corporation Tumor Genomics Product Overview
10.6.3 Fluidigm Corporation Tumor Genomics Product Market Performance
10.6.4 Fluidigm Corporation Business Overview
10.6.5 Fluidigm Corporation Recent Developments
10.7 General Electric Company
10.7.1 General Electric Company Basic Information
10.7.2 General Electric Company Tumor Genomics Product Overview
10.7.3 General Electric Company Tumor Genomics Product Market Performance
10.7.4 General Electric Company Business Overview
10.7.5 General Electric Company Recent Developments
10.8 IlluminaInc.
10.8.1 IlluminaInc. Basic Information
10.8.2 IlluminaInc. Tumor Genomics Product Overview
10.8.3 IlluminaInc. Tumor Genomics Product Market Performance
10.8.4 IlluminaInc. Business Overview
10.8.5 IlluminaInc. Recent Developments
10.9 Merck KGaA
10.9.1 Merck KGaA Basic Information
10.9.2 Merck KGaA Tumor Genomics Product Overview
10.9.3 Merck KGaA Tumor Genomics Product Market Performance
10.9.4 Merck KGaA Business Overview
10.9.5 Merck KGaA Recent Developments
10.10 Myriad GeneticsInc.
10.10.1 Myriad GeneticsInc. Basic Information
10.10.2 Myriad GeneticsInc. Tumor Genomics Product Overview
10.10.3 Myriad GeneticsInc. Tumor Genomics Product Market Performance
10.10.4 Myriad GeneticsInc. Business Overview
10.10.5 Myriad GeneticsInc. Recent Developments
10.11 Pacific Biosciences of CaliforniaInc.
10.11.1 Pacific Biosciences of CaliforniaInc. Basic Information
10.11.2 Pacific Biosciences of CaliforniaInc. Tumor Genomics Product Overview
10.11.3 Pacific Biosciences of CaliforniaInc. Tumor Genomics Product Market Performance
10.11.4 Pacific Biosciences of CaliforniaInc. Business Overview
10.11.5 Pacific Biosciences of CaliforniaInc. Recent Developments
10.12 PerkinElmer
10.12.1 PerkinElmer Basic Information
10.12.2 PerkinElmer Tumor Genomics Product Overview
10.12.3 PerkinElmer Tumor Genomics Product Market Performance
10.12.4 PerkinElmer Business Overview
10.12.5 PerkinElmer Recent Developments
10.13 QIAGEN
10.13.1 QIAGEN Basic Information
10.13.2 QIAGEN Tumor Genomics Product Overview
10.13.3 QIAGEN Tumor Genomics Product Market Performance
10.13.4 QIAGEN Business Overview
10.13.5 QIAGEN Recent Developments
10.14 Siemens Healthineers AG
10.14.1 Siemens Healthineers AG Basic Information
10.14.2 Siemens Healthineers AG Tumor Genomics Product Overview
10.14.3 Siemens Healthineers AG Tumor Genomics Product Market Performance
10.14.4 Siemens Healthineers AG Business Overview
10.14.5 Siemens Healthineers AG Recent Developments
10.15 Thermo Fisher Scientific Inc.
10.15.1 Thermo Fisher Scientific Inc. Basic Information
10.15.2 Thermo Fisher Scientific Inc. Tumor Genomics Product Overview
10.15.3 Thermo Fisher Scientific Inc. Tumor Genomics Product Market Performance
10.15.4 Thermo Fisher Scientific Inc. Business Overview
10.15.5 Thermo Fisher Scientific Inc. Recent Developments
11 TUMOR GENOMICS MARKET FORECAST BY REGION
11.1 Global Tumor Genomics Market Size Forecast
11.2 Global Tumor Genomics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Tumor Genomics Market Size Forecast by Country
11.2.3 Asia Pacific Tumor Genomics Market Size Forecast by Region
11.2.4 South America Tumor Genomics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Tumor Genomics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Tumor Genomics Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Tumor Genomics by Type (2026-2033)
12.1.2 Global Tumor Genomics Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Tumor Genomics by Type (2026-2033)
12.2 Global Tumor Genomics Market Forecast by Application (2026-2033)
12.2.1 Global Tumor Genomics Sales (K Units) Forecast by Application
12.2.2 Global Tumor Genomics Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tumor Genomics Market Size Comparison by Region (M USD)
Table 5. Global Tumor Genomics Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Tumor Genomics Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Tumor Genomics Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Tumor Genomics Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Genomics as of 2024)
Table 10. Global Market Tumor Genomics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Tumor Genomics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Tumor Genomics Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Tumor Genomics Sales by Type (K Units)
Table 26. Global Tumor Genomics Market Size by Type (M USD)
Table 27. Global Tumor Genomics Sales (K Units) by Type (2020-2025)
Table 28. Global Tumor Genomics Sales Market Share by Type (2020-2025)
Table 29. Global Tumor Genomics Market Size (M USD) by Type (2020-2025)
Table 30. Global Tumor Genomics Market Size Share by Type (2020-2025)
Table 31. Global Tumor Genomics Price (USD/Unit) by Type (2020-2025)
Table 32. Global Tumor Genomics Sales (K Units) by Application
Table 33. Global Tumor Genomics Market Size by Application
Table 34. Global Tumor Genomics Sales by Application (2020-2025) & (K Units)
Table 35. Global Tumor Genomics Sales Market Share by Application (2020-2025)
Table 36. Global Tumor Genomics Market Size by Application (2020-2025) & (M USD)
Table 37. Global Tumor Genomics Market Share by Application (2020-2025)
Table 38. Global Tumor Genomics Sales Growth Rate by Application (2020-2025)
Table 39. Global Tumor Genomics Sales by Region (2020-2025) & (K Units)
Table 40. Global Tumor Genomics Sales Market Share by Region (2020-2025)
Table 41. Global Tumor Genomics Market Size by Region (2020-2025) & (M USD)
Table 42. Global Tumor Genomics Market Size Market Share by Region (2020-2025)
Table 43. North America Tumor Genomics Sales by Country (2020-2025) & (K Units)
Table 44. North America Tumor Genomics Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Tumor Genomics Sales by Country (2020-2025) & (K Units)
Table 46. Europe Tumor Genomics Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Tumor Genomics Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Tumor Genomics Market Size by Region (2020-2025) & (M USD)
Table 49. South America Tumor Genomics Sales by Country (2020-2025) & (K Units)
Table 50. South America Tumor Genomics Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Tumor Genomics Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Tumor Genomics Market Size by Region (2020-2025) & (M USD)
Table 53. Global Tumor Genomics Production (K Units) by Region(2020-2025)
Table 54. Global Tumor Genomics Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Tumor Genomics Revenue Market Share by Region (2020-2025)
Table 56. Global Tumor Genomics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Tumor Genomics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Tumor Genomics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Tumor Genomics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Tumor Genomics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Abbott Laboratories Basic Information
Table 62. Abbott Laboratories Tumor Genomics Product Overview
Table 63. Abbott Laboratories Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories SWOT Analysis
Table 66. Abbott Laboratories Recent Developments
Table 67. Agilent TechnologiesInc Basic Information
Table 68. Agilent TechnologiesInc Tumor Genomics Product Overview
Table 69. Agilent TechnologiesInc Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Agilent TechnologiesInc Business Overview
Table 71. Agilent TechnologiesInc SWOT Analysis
Table 72. Agilent TechnologiesInc Recent Developments
Table 73. Bio-Rad LaboratoriesInc. Basic Information
Table 74. Bio-Rad LaboratoriesInc. Tumor Genomics Product Overview
Table 75. Bio-Rad LaboratoriesInc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Bio-Rad LaboratoriesInc. Business Overview
Table 77. Bio-Rad LaboratoriesInc. SWOT Analysis
Table 78. Bio-Rad LaboratoriesInc. Recent Developments
Table 79. Danaher Corporation Basic Information
Table 80. Danaher Corporation Tumor Genomics Product Overview
Table 81. Danaher Corporation Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Danaher Corporation Business Overview
Table 83. Danaher Corporation Recent Developments
Table 84. F. Hoffmann-La Roche Ltd Basic Information
Table 85. F. Hoffmann-La Roche Ltd Tumor Genomics Product Overview
Table 86. F. Hoffmann-La Roche Ltd Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. F. Hoffmann-La Roche Ltd Business Overview
Table 88. F. Hoffmann-La Roche Ltd Recent Developments
Table 89. Fluidigm Corporation Basic Information
Table 90. Fluidigm Corporation Tumor Genomics Product Overview
Table 91. Fluidigm Corporation Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Fluidigm Corporation Business Overview
Table 93. Fluidigm Corporation Recent Developments
Table 94. General Electric Company Basic Information
Table 95. General Electric Company Tumor Genomics Product Overview
Table 96. General Electric Company Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. General Electric Company Business Overview
Table 98. General Electric Company Recent Developments
Table 99. IlluminaInc. Basic Information
Table 100. IlluminaInc. Tumor Genomics Product Overview
Table 101. IlluminaInc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. IlluminaInc. Business Overview
Table 103. IlluminaInc. Recent Developments
Table 104. Merck KGaA Basic Information
Table 105. Merck KGaA Tumor Genomics Product Overview
Table 106. Merck KGaA Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Merck KGaA Business Overview
Table 108. Merck KGaA Recent Developments
Table 109. Myriad GeneticsInc. Basic Information
Table 110. Myriad GeneticsInc. Tumor Genomics Product Overview
Table 111. Myriad GeneticsInc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Myriad GeneticsInc. Business Overview
Table 113. Myriad GeneticsInc. Recent Developments
Table 114. Pacific Biosciences of CaliforniaInc. Basic Information
Table 115. Pacific Biosciences of CaliforniaInc. Tumor Genomics Product Overview
Table 116. Pacific Biosciences of CaliforniaInc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Pacific Biosciences of CaliforniaInc. Business Overview
Table 118. Pacific Biosciences of CaliforniaInc. Recent Developments
Table 119. PerkinElmer Basic Information
Table 120. PerkinElmer Tumor Genomics Product Overview
Table 121. PerkinElmer Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. PerkinElmer Business Overview
Table 123. PerkinElmer Recent Developments
Table 124. QIAGEN Basic Information
Table 125. QIAGEN Tumor Genomics Product Overview
Table 126. QIAGEN Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. QIAGEN Business Overview
Table 128. QIAGEN Recent Developments
Table 129. Siemens Healthineers AG Basic Information
Table 130. Siemens Healthineers AG Tumor Genomics Product Overview
Table 131. Siemens Healthineers AG Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Siemens Healthineers AG Business Overview
Table 133. Siemens Healthineers AG Recent Developments
Table 134. Thermo Fisher Scientific Inc. Basic Information
Table 135. Thermo Fisher Scientific Inc. Tumor Genomics Product Overview
Table 136. Thermo Fisher Scientific Inc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Thermo Fisher Scientific Inc. Business Overview
Table 138. Thermo Fisher Scientific Inc. Recent Developments
Table 139. Global Tumor Genomics Sales Forecast by Region (2026-2033) & (K Units)
Table 140. Global Tumor Genomics Market Size Forecast by Region (2026-2033) & (M USD)
Table 141. North America Tumor Genomics Sales Forecast by Country (2026-2033) & (K Units)
Table 142. North America Tumor Genomics Market Size Forecast by Country (2026-2033) & (M USD)
Table 143. Europe Tumor Genomics Sales Forecast by Country (2026-2033) & (K Units)
Table 144. Europe Tumor Genomics Market Size Forecast by Country (2026-2033) & (M USD)
Table 145. Asia Pacific Tumor Genomics Sales Forecast by Region (2026-2033) & (K Units)
Table 146. Asia Pacific Tumor Genomics Market Size Forecast by Region (2026-2033) & (M USD)
Table 147. South America Tumor Genomics Sales Forecast by Country (2026-2033) & (K Units)
Table 148. South America Tumor Genomics Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Middle East and Africa Tumor Genomics Sales Forecast by Country (2026-2033) & (Units)
Table 150. Middle East and Africa Tumor Genomics Market Size Forecast by Country (2026-2033) & (M USD)
Table 151. Global Tumor Genomics Sales Forecast by Type (2026-2033) & (K Units)
Table 152. Global Tumor Genomics Market Size Forecast by Type (2026-2033) & (M USD)
Table 153. Global Tumor Genomics Price Forecast by Type (2026-2033) & (USD/Unit)
Table 154. Global Tumor Genomics Sales (K Units) Forecast by Application (2026-2033)
Table 155. Global Tumor Genomics Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tumor Genomics Market Size Comparison by Region (M USD)
Table 5. Global Tumor Genomics Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Tumor Genomics Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Tumor Genomics Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Tumor Genomics Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Genomics as of 2024)
Table 10. Global Market Tumor Genomics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Tumor Genomics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Tumor Genomics Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Tumor Genomics Sales by Type (K Units)
Table 26. Global Tumor Genomics Market Size by Type (M USD)
Table 27. Global Tumor Genomics Sales (K Units) by Type (2020-2025)
Table 28. Global Tumor Genomics Sales Market Share by Type (2020-2025)
Table 29. Global Tumor Genomics Market Size (M USD) by Type (2020-2025)
Table 30. Global Tumor Genomics Market Size Share by Type (2020-2025)
Table 31. Global Tumor Genomics Price (USD/Unit) by Type (2020-2025)
Table 32. Global Tumor Genomics Sales (K Units) by Application
Table 33. Global Tumor Genomics Market Size by Application
Table 34. Global Tumor Genomics Sales by Application (2020-2025) & (K Units)
Table 35. Global Tumor Genomics Sales Market Share by Application (2020-2025)
Table 36. Global Tumor Genomics Market Size by Application (2020-2025) & (M USD)
Table 37. Global Tumor Genomics Market Share by Application (2020-2025)
Table 38. Global Tumor Genomics Sales Growth Rate by Application (2020-2025)
Table 39. Global Tumor Genomics Sales by Region (2020-2025) & (K Units)
Table 40. Global Tumor Genomics Sales Market Share by Region (2020-2025)
Table 41. Global Tumor Genomics Market Size by Region (2020-2025) & (M USD)
Table 42. Global Tumor Genomics Market Size Market Share by Region (2020-2025)
Table 43. North America Tumor Genomics Sales by Country (2020-2025) & (K Units)
Table 44. North America Tumor Genomics Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Tumor Genomics Sales by Country (2020-2025) & (K Units)
Table 46. Europe Tumor Genomics Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Tumor Genomics Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Tumor Genomics Market Size by Region (2020-2025) & (M USD)
Table 49. South America Tumor Genomics Sales by Country (2020-2025) & (K Units)
Table 50. South America Tumor Genomics Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Tumor Genomics Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Tumor Genomics Market Size by Region (2020-2025) & (M USD)
Table 53. Global Tumor Genomics Production (K Units) by Region(2020-2025)
Table 54. Global Tumor Genomics Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Tumor Genomics Revenue Market Share by Region (2020-2025)
Table 56. Global Tumor Genomics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Tumor Genomics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Tumor Genomics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Tumor Genomics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Tumor Genomics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Abbott Laboratories Basic Information
Table 62. Abbott Laboratories Tumor Genomics Product Overview
Table 63. Abbott Laboratories Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories SWOT Analysis
Table 66. Abbott Laboratories Recent Developments
Table 67. Agilent TechnologiesInc Basic Information
Table 68. Agilent TechnologiesInc Tumor Genomics Product Overview
Table 69. Agilent TechnologiesInc Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Agilent TechnologiesInc Business Overview
Table 71. Agilent TechnologiesInc SWOT Analysis
Table 72. Agilent TechnologiesInc Recent Developments
Table 73. Bio-Rad LaboratoriesInc. Basic Information
Table 74. Bio-Rad LaboratoriesInc. Tumor Genomics Product Overview
Table 75. Bio-Rad LaboratoriesInc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Bio-Rad LaboratoriesInc. Business Overview
Table 77. Bio-Rad LaboratoriesInc. SWOT Analysis
Table 78. Bio-Rad LaboratoriesInc. Recent Developments
Table 79. Danaher Corporation Basic Information
Table 80. Danaher Corporation Tumor Genomics Product Overview
Table 81. Danaher Corporation Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Danaher Corporation Business Overview
Table 83. Danaher Corporation Recent Developments
Table 84. F. Hoffmann-La Roche Ltd Basic Information
Table 85. F. Hoffmann-La Roche Ltd Tumor Genomics Product Overview
Table 86. F. Hoffmann-La Roche Ltd Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. F. Hoffmann-La Roche Ltd Business Overview
Table 88. F. Hoffmann-La Roche Ltd Recent Developments
Table 89. Fluidigm Corporation Basic Information
Table 90. Fluidigm Corporation Tumor Genomics Product Overview
Table 91. Fluidigm Corporation Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Fluidigm Corporation Business Overview
Table 93. Fluidigm Corporation Recent Developments
Table 94. General Electric Company Basic Information
Table 95. General Electric Company Tumor Genomics Product Overview
Table 96. General Electric Company Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. General Electric Company Business Overview
Table 98. General Electric Company Recent Developments
Table 99. IlluminaInc. Basic Information
Table 100. IlluminaInc. Tumor Genomics Product Overview
Table 101. IlluminaInc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. IlluminaInc. Business Overview
Table 103. IlluminaInc. Recent Developments
Table 104. Merck KGaA Basic Information
Table 105. Merck KGaA Tumor Genomics Product Overview
Table 106. Merck KGaA Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Merck KGaA Business Overview
Table 108. Merck KGaA Recent Developments
Table 109. Myriad GeneticsInc. Basic Information
Table 110. Myriad GeneticsInc. Tumor Genomics Product Overview
Table 111. Myriad GeneticsInc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Myriad GeneticsInc. Business Overview
Table 113. Myriad GeneticsInc. Recent Developments
Table 114. Pacific Biosciences of CaliforniaInc. Basic Information
Table 115. Pacific Biosciences of CaliforniaInc. Tumor Genomics Product Overview
Table 116. Pacific Biosciences of CaliforniaInc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Pacific Biosciences of CaliforniaInc. Business Overview
Table 118. Pacific Biosciences of CaliforniaInc. Recent Developments
Table 119. PerkinElmer Basic Information
Table 120. PerkinElmer Tumor Genomics Product Overview
Table 121. PerkinElmer Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. PerkinElmer Business Overview
Table 123. PerkinElmer Recent Developments
Table 124. QIAGEN Basic Information
Table 125. QIAGEN Tumor Genomics Product Overview
Table 126. QIAGEN Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. QIAGEN Business Overview
Table 128. QIAGEN Recent Developments
Table 129. Siemens Healthineers AG Basic Information
Table 130. Siemens Healthineers AG Tumor Genomics Product Overview
Table 131. Siemens Healthineers AG Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Siemens Healthineers AG Business Overview
Table 133. Siemens Healthineers AG Recent Developments
Table 134. Thermo Fisher Scientific Inc. Basic Information
Table 135. Thermo Fisher Scientific Inc. Tumor Genomics Product Overview
Table 136. Thermo Fisher Scientific Inc. Tumor Genomics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Thermo Fisher Scientific Inc. Business Overview
Table 138. Thermo Fisher Scientific Inc. Recent Developments
Table 139. Global Tumor Genomics Sales Forecast by Region (2026-2033) & (K Units)
Table 140. Global Tumor Genomics Market Size Forecast by Region (2026-2033) & (M USD)
Table 141. North America Tumor Genomics Sales Forecast by Country (2026-2033) & (K Units)
Table 142. North America Tumor Genomics Market Size Forecast by Country (2026-2033) & (M USD)
Table 143. Europe Tumor Genomics Sales Forecast by Country (2026-2033) & (K Units)
Table 144. Europe Tumor Genomics Market Size Forecast by Country (2026-2033) & (M USD)
Table 145. Asia Pacific Tumor Genomics Sales Forecast by Region (2026-2033) & (K Units)
Table 146. Asia Pacific Tumor Genomics Market Size Forecast by Region (2026-2033) & (M USD)
Table 147. South America Tumor Genomics Sales Forecast by Country (2026-2033) & (K Units)
Table 148. South America Tumor Genomics Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Middle East and Africa Tumor Genomics Sales Forecast by Country (2026-2033) & (Units)
Table 150. Middle East and Africa Tumor Genomics Market Size Forecast by Country (2026-2033) & (M USD)
Table 151. Global Tumor Genomics Sales Forecast by Type (2026-2033) & (K Units)
Table 152. Global Tumor Genomics Market Size Forecast by Type (2026-2033) & (M USD)
Table 153. Global Tumor Genomics Price Forecast by Type (2026-2033) & (USD/Unit)
Table 154. Global Tumor Genomics Sales (K Units) Forecast by Application (2026-2033)
Table 155. Global Tumor Genomics Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Tumor Genomics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tumor Genomics Market Size (M USD), 2024-2033
Figure 5. Global Tumor Genomics Market Size (M USD) (2020-2033)
Figure 6. Global Tumor Genomics Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tumor Genomics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Tumor Genomics Product Life Cycle
Figure 13. Tumor Genomics Sales Share by Manufacturers in 2024
Figure 14. Global Tumor Genomics Revenue Share by Manufacturers in 2024
Figure 15. Tumor Genomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Tumor Genomics Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Tumor Genomics Revenue in 2024
Figure 18. Industry Chain Map of Tumor Genomics
Figure 19. Global Tumor Genomics Market PEST Analysis
Figure 20. Global Tumor Genomics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Tumor Genomics Market Share by Type
Figure 27. Sales Market Share of Tumor Genomics by Type (2020-2025)
Figure 28. Sales Market Share of Tumor Genomics by Type in 2024
Figure 29. Market Size Share of Tumor Genomics by Type (2020-2025)
Figure 30. Market Size Share of Tumor Genomics by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Tumor Genomics Market Share by Application
Figure 33. Global Tumor Genomics Sales Market Share by Application (2020-2025)
Figure 34. Global Tumor Genomics Sales Market Share by Application in 2024
Figure 35. Global Tumor Genomics Market Share by Application (2020-2025)
Figure 36. Global Tumor Genomics Market Share by Application in 2024
Figure 37. Global Tumor Genomics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Tumor Genomics Sales Market Share by Region (2020-2025)
Figure 39. Global Tumor Genomics Market Size Market Share by Region (2020-2025)
Figure 40. North America Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Tumor Genomics Sales Market Share by Country in 2024
Figure 43. North America Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Tumor Genomics Market Size Market Share by Country in 2024
Figure 45. U.S. Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Tumor Genomics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Tumor Genomics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Tumor Genomics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Tumor Genomics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Tumor Genomics Sales Market Share by Country in 2024
Figure 53. Europe Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Tumor Genomics Market Size Market Share by Country in 2024
Figure 55. Germany Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Tumor Genomics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Tumor Genomics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Tumor Genomics Market Size Market Share by Region in 2024
Figure 68. China Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Tumor Genomics Sales and Growth Rate (K Units)
Figure 79. South America Tumor Genomics Sales Market Share by Country in 2024
Figure 80. South America Tumor Genomics Market Size and Growth Rate (M USD)
Figure 81. South America Tumor Genomics Market Size Market Share by Country in 2024
Figure 82. Brazil Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Tumor Genomics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Tumor Genomics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Tumor Genomics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Tumor Genomics Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Tumor Genomics Production Market Share by Region (2020-2025)
Figure 103. North America Tumor Genomics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Tumor Genomics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Tumor Genomics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Tumor Genomics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Tumor Genomics Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Tumor Genomics Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Tumor Genomics Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Tumor Genomics Market Share Forecast by Type (2026-2033)
Figure 111. Global Tumor Genomics Sales Forecast by Application (2026-2033)
Figure 112. Global Tumor Genomics Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Tumor Genomics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tumor Genomics Market Size (M USD), 2024-2033
Figure 5. Global Tumor Genomics Market Size (M USD) (2020-2033)
Figure 6. Global Tumor Genomics Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tumor Genomics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Tumor Genomics Product Life Cycle
Figure 13. Tumor Genomics Sales Share by Manufacturers in 2024
Figure 14. Global Tumor Genomics Revenue Share by Manufacturers in 2024
Figure 15. Tumor Genomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Tumor Genomics Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Tumor Genomics Revenue in 2024
Figure 18. Industry Chain Map of Tumor Genomics
Figure 19. Global Tumor Genomics Market PEST Analysis
Figure 20. Global Tumor Genomics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Tumor Genomics Market Share by Type
Figure 27. Sales Market Share of Tumor Genomics by Type (2020-2025)
Figure 28. Sales Market Share of Tumor Genomics by Type in 2024
Figure 29. Market Size Share of Tumor Genomics by Type (2020-2025)
Figure 30. Market Size Share of Tumor Genomics by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Tumor Genomics Market Share by Application
Figure 33. Global Tumor Genomics Sales Market Share by Application (2020-2025)
Figure 34. Global Tumor Genomics Sales Market Share by Application in 2024
Figure 35. Global Tumor Genomics Market Share by Application (2020-2025)
Figure 36. Global Tumor Genomics Market Share by Application in 2024
Figure 37. Global Tumor Genomics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Tumor Genomics Sales Market Share by Region (2020-2025)
Figure 39. Global Tumor Genomics Market Size Market Share by Region (2020-2025)
Figure 40. North America Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Tumor Genomics Sales Market Share by Country in 2024
Figure 43. North America Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Tumor Genomics Market Size Market Share by Country in 2024
Figure 45. U.S. Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Tumor Genomics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Tumor Genomics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Tumor Genomics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Tumor Genomics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Tumor Genomics Sales Market Share by Country in 2024
Figure 53. Europe Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Tumor Genomics Market Size Market Share by Country in 2024
Figure 55. Germany Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Tumor Genomics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Tumor Genomics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Tumor Genomics Market Size Market Share by Region in 2024
Figure 68. China Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Tumor Genomics Sales and Growth Rate (K Units)
Figure 79. South America Tumor Genomics Sales Market Share by Country in 2024
Figure 80. South America Tumor Genomics Market Size and Growth Rate (M USD)
Figure 81. South America Tumor Genomics Market Size Market Share by Country in 2024
Figure 82. Brazil Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Tumor Genomics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Tumor Genomics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Tumor Genomics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Tumor Genomics Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Tumor Genomics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Tumor Genomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Tumor Genomics Production Market Share by Region (2020-2025)
Figure 103. North America Tumor Genomics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Tumor Genomics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Tumor Genomics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Tumor Genomics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Tumor Genomics Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Tumor Genomics Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Tumor Genomics Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Tumor Genomics Market Share Forecast by Type (2026-2033)
Figure 111. Global Tumor Genomics Sales Forecast by Application (2026-2033)
Figure 112. Global Tumor Genomics Market Share Forecast by Application (2026-2033)
